Teachers Advisors’s Rein Therapeutics RNTX Stock Holding History

Teachers Advisors’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-295	Closed	-$62K	–	3052
2017 Q4	$62K	Hold	295	–	–	﹤0.01%	3025
2017 Q3	$79K	Buy	+295	New	+$74K	﹤0.01%	3043

Other funds holding RNTX

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Teachers Advisors's RNTX Position: Q1 2018 in Review

Teachers Advisors sold out of Rein Therapeutics (RNTX) in Q1 2018, closing a stake of 295 shares — an estimated $62K sold.

Teachers Advisors first reported a position in RNTX in Q3 2017 and held it in 2 quarters. The position peaked at $79K in Q3 2017. 27 funds tracked by Wall St. Rank hold RNTX as of Q1 2018.

Teachers Advisors reported no remaining Rein Therapeutics position as of Q1 2018 after selling out during the quarter.
Teachers Advisors sold 295 Rein Therapeutics shares in Q1 2018, an estimated $62K.
Teachers Advisors first reported a position in Rein Therapeutics in Q3 2017 and held it in 2 quarters.
Teachers Advisors's Rein Therapeutics position peaked at $79K in Q3 2017.
27 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2018.

Based on Teachers Advisors's 13F filing for Q1 2018, filed 14 May 2018.